Efrat Assa Kunik - 15 Dec 2021 Form 3 Insider Report for Orgenesis Inc. (ORGS)

Role
Chief Development Officer
Signature
/s/ Efrat Assa Kunik
Issuer symbol
ORGS
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
3
Filing time
10 Jan 2022, 05:10:59 UTC
Next filing
16 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ORGS Stock Option 15 Dec 2021 Common Stock 16,667 $4.80 Direct F1
holding ORGS Stock Option 15 Dec 2021 Common Stock 15,000 $5.99 Direct F2
holding ORGS Stock Option 15 Dec 2021 Common Stock 15,000 $2.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are fully vested.
F2 These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a four-year period, beginning October 22, 2018.
F3 These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a two-year period, beginning March 31, 2020.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney